Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, ...

March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for ...

A new study from the Hebrew University of Jerusalem suggests that non-intoxicating cannabis compounds CBD and CBG may help ...

Naturally occurring chemicals in cannabis have been shown to reduce cholesterol–and the risk of deadly fatty liver disease, ...

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

Alcohol-associated liver disease (ALD) remains a leading cause of cirrhosis and liver-related mortality worldwide, with few effective therapies.

Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...

CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

CBD and CBG may help the liver recharge and clean itself—offering a promising new plant-based strategy against fatty liver disease.

Add Yahoo as a preferred source to see more of our stories on Google. A new study in US reveals a troubling rise in advanced liver disease among heavy drinkers. Surprisingly, this increase isn’t due ...

In experiments on pigs, researchers found that some formula fats can strain the newborn liver far earlier than expected.

Researchers have discovered that non-psychoactive cannabis compounds, CBD and CBG, can significantly reduce liver fat and ...